KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Telerx, a 30-year leader in multi-channel engagement of consumers, patients, healthcare professionals and enterprise personnel, today announced plans to hire more than 100 customer service associates across four of the company’s major contact centers in Wilkes-Barre, Pa. and Pittston, Pa., beginning immediately. Telerx, along with its life sciences division, C3i Healthcare Connections, is seeking to increase its customer service team as it strives to effectively deliver unparalleled customer service engagement solutions to both the consumer packaged goods and life sciences industries.
Currently employing more than 800 people and serving more than 27 clients at the four Wilkes-Barre and Pittston locations, Telerx is hiring full-time and part-time Help Desk Technicians and Customer Service Account Representatives, including some work from home positions. Associates will handle inbound and outbound phone calls, email support, or chat support. All new team members will receive extensive training regardless of prior experience. The Wilkes-Barre and Pittston locations handle thousands of multi-channel contacts on a daily basis, as well as provide product and rebate check fulfillment services on behalf of the nation’s leading consumer brands.
“As Telerx and C3i Healthcare Connections continue to grow and deliver more ways for our clients to interact with their customers, we are aggressively looking for good people who are dedicated to working hard and maximizing the many opportunities for continued career growth within our organization. It’s driven by the great culture and community presence we’ve built in these areas over the past 16 years,” said Dave Desch, Telerx’s Chief Human Resources Officer.
Desch added, “While the unemployment rate continues to decrease, we are committed to offering competitive career opportunities through a variety of positions that offer flexible hours, pay above the minimum wage and don’t require a college degree. Many of these open positions are a great fit for recent high school and college graduates or people looking to rejoin the workforce.”
Telerx delivers customer care and experience services to Fortune 1000 companies and more than 700 brands in the food & beverage, CPG, pharmaceutical and life sciences industries and has operated its locations in the Wilkes-Barre and Pittston areas since 1999. In May 2014, Telerx acquired C3i Healthcare Connections to add to the company’s existing programs in support of the global pharmaceutical industry.
For more than 30 years, Telerx, a subsidiary of Merck & Co., Inc., has provided customer and patient care services to Fortune 1000 companies in the pharmaceutical, healthcare and consumer packaged goods industries. Using advanced technology, the company takes a customized approach to create highly successful customer experiences for millions of consumers, patients and healthcare providers each year and provide valuable insights that help drive better processes and outcomes. More than 90 percent of the company’s clients are FDA-regulated. Headquartered in King of Prussia, Pa., Telerx has additional contact centers in Horsham, Pittston and Wilkes-Barre, Pa.; El Paso, Texas; Kings Mountain, N.C.; Morristown and Little Falls, N.J.; Hyderabad, India; Sofia, Bulgaria; and Dalian, China. For more information, visit Telerx.com or connect via Facebook, Twitter and LinkedIn.
Merck is a global healthcare leader working to help the world be well. Merck is known as MSD outside the United States and Canada. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to healthcare through far-reaching policies, programs and partnerships. For more information, visit www.merck.com and connect with us on Twitter, Facebook and YouTube.
Forward-Looking Statement of Merck & Co. Inc., Kenilworth, NJ, USA
This news release of Merck & Co., Inc., Kenilworth, NJ, USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.
Risks and uncertainties include, but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and healthcare legislation in the United States and internationally; global trends toward healthcare cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.
The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2014 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).